Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation

被引：6

作者：

Inamoto, Yoshihiro ^{[1
]}

Petricek, Igor ^{[2
]}

Burns, Linda ^{[3
]}

Chhabra, Saurabh ^{[4
]}

DeFilipp, Zachariah ^{[5
]}

Hematti, Peiman ^{[6
]}

Rovo, Alicia ^{[7
]}

Schears, Raquel ^{[8
]}

Shah, Ami ^{[9
]}

Agrawal, Vaibhav ^{[10
]}

Ahmed, Aisha ^{[11
]}

Ahmed, Ibrahim ^{[12
]}

Ali, Asim ^{[13
]}

Aljurf, Mahmoud ^{[14
]}

Alkhateeb, Hassan ^{[8
]}

Beitinjaneh, Amer ^{[15
]}

Bhatt, Neel ^{[16
]}

Buchbinder, Dave ^{[17
]}

Byrne, Michael ^{[18
]}

Callander, Natalie ^{[19
]}

Fahnehjelm, Kristina ^{[20
,21
]}

Farhadfar, Nosha ^{[22
]}

Gale, Robert Peter ^{[23
]}

Ganguly, Siddhartha ^{[24
]}

Hashmi, Shahrukh ^{[14
]}

Hildebrandt, Gerhard C. ^{[25
]}

Horn, Erich ^{[22
]}

Jakubowski, Ann ^{[26
]}

Kamble, Rammurti T. ^{[27
]}

Law, Jason ^{[28
]}

Lee, Catherine ^{[29
]}

Nathan, Sunita ^{[30
]}

Penack, Olaf ^{[31
]}

Pingali, Ravi ^{[32
]}

Prasad, Pinki ^{[33
]}

Pulanic, Drazen ^{[34
,35
,36
]}

Rotz, Seth ^{[37
]}

Shreenivas, Aditya ^{[38
]}

Steinberg, Amir ^{[38
]}

Tabbara, Khalid ^{[39
]}

Tichelli, Andre ^{[40
]}

Wirk, Baldeep ^{[41
]}

Yared, Jean ^{[42
]}

Basak, Grzegorz W. ^{[43
]}

Battiwalla, Minoo ^{[44
]}

Duarte, Rafael ^{[45
]}

Savani, Bipin N. ^{[18
]}

Flowers, Mary E. D. ^{[46
]}

Shaw, Bronwen E. ^{[16
]}

Valdes-Sanz, Nuria ^{[47
]}

机构：

[1] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[2] Zagreb Univ Clin Hosp, Dept Ophthalmol, Zagreb, Croatia

[3] Natl Marrow Donor Program Be Match, Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[4] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

[5] Massachusetts Gen Hosp, Blood & Marrow Transplant Program, Boston, MA 02114 USA

[6] Univ Wisconsin Hosp & Clin, Dept Med, Div Hematol Oncol Bone Marrow Transplantat, Madison, WI 53792 USA

[7] Bern Univ Hosp, Inselspital, Bern, Switzerland

[8] Mayo Clin Rochester, Div Hematol, Rochester, MN USA

[9] Lucille Packard Childrens Hosp, Stanford Sch Med, Div Stem Cell Transplantat & Regenerat Med, Palo Alto, CA 94304 USA

[10] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA

[11] Univ Calif San Francisco, San Francisco, CA 94143 USA

[12] Childrens Mercy Hosp & Clin, Dept Hematol Oncol & Bone Marrow Transplantat, Kansas City, MO USA

[13] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada

[14] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh, Saudi Arabia

[15] Univ Miami, Miami, FL USA

[16] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Program, Milwaukee, WI 53226 USA

[17] Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA 92668 USA

[18] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA

[19] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[20] Karolinska Inst, St Erik Eye Hosp, Dept Clin Neurosci, Stockholm, Sweden

[21] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden

[22] Univ Florida, Hlth Shands Hosp, Gainesville, FL USA

[23] Imperial Coll London, Hematol Res Ctr, Dept Med, Div Expt Med, London, England

[24] Univ Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA

[25] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA

[26] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, 1275 York Ave, New York, NY 10021 USA

[27] Baylor Coll Med, Ctr Cell & Gene Therapy, Div Hematol & Oncol, Houston, TX 77030 USA

[28] Tufts Med Ctr, Boston, MA 02111 USA

[29] Univ Utah, Utah Blood & Marrow Transplant Program, Huntsman Canc Inst, Salt Lake City, UT USA

[30] Rush Univ, Med Ctr, Chicago, IL 60612 USA

[31] Charite, Dept Internal Med, Div Hematol & Oncol, Campus Rudolf Virchow, Berlin, Germany

[32] Houston Methodist Hosp, Houston, TX 77030 USA

[33] Lousiana State Univ Childrens Hosp, New Orleans, LA USA

[34] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Hematol, Zagreb, Croatia

[35] Univ Zagreb, Sch Med, Zagreb, Croatia

[36] Josip Juraj Strossmayer Univ Osijek, Fac Med, Osijek, Croatia

[37] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[38] Mt Sinai Hosp, Div Hematol & Oncol, New York, NY 10029 USA

[39] Johns Hopkins Med, Wilmer Eye Inst, Baltimore, MD USA

[40] Univ Hosp Basel, Hematol, Basel, Switzerland

[41] Seattle Canc Care Alliance, Div Bone Marrow Transplant, Washington, DC USA

[42] Univ Maryland, Dept Med, Greenebaum Comprehens Canc Ctr, Div Hematol Oncol,Blood & Marrow Transplantat Pro, Baltimore, MD 21201 USA

[43] Med Univ Warsaw, Dept Hematol Oncol & Internal Med, Warsaw, Poland

[44] Sarah Cannon Ctr Blood Canc, Hematol Branch, Nashville, TN USA

[45] Puerta de Hierro Majadahonda Univ Hosp, Hematopoiet Transplantat & Hematooncol Sect, Madrid, Spain

[46] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA

[47] Puerta de Hierro Majadahonda Univ Hosp, Dept Ophthalmol, Madrid, Spain

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 05期

关键词：

Hematopoietic cell; transplantation; Complication; Eye; Review; Prevention; Treatment; NERVOUS-SYSTEM LYMPHOMA; TERM-FOLLOW-UP; CYTOMEGALOVIRUS RETINITIS; RISK-FACTORS; RANDOMIZED-TRIAL; MACULAR EDEMA; RETINAL MICROVASCULOPATHY; INTRAOCULAR-PRESSURE; ADENOVIRUS INFECTION; TOXOPLASMA-GONDII;

D O I：

10.1016/j.bbmt.2018.11.033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Non-graft-versus-host disease (GVHD) ocular complications are generally uncommon after hematopoietic cell transplantation (HCT) but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide an expert review of non-GVHD ocular complications in a collaboration between transplantation physicians and ophthalmologists through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Complications discussed in this review include cataracts, glaucoma, ocular infections, ocular involvement with malignancy, ischemic microvascular retinopathy, central retinal vein occlusion, retinal hemorrhage, retinal detachment and ocular toxicities associated with medications. We summarize the incidence, risk factors, screening, prevention, and treatment of individual complications and generate evidence-based recommendations. Baseline ocular evaluation before HCT should be considered in all patients who undergo HCT. Follow-up evaluations should be considered according to clinical signs and symptoms and risk factors. Better preventive strategies and treatments remain to be investigated for individual ocular complications after HCT. Both transplantation physicians and ophthalmologists should be knowledgeable about nonGVHD ocular complications and provide comprehensive collaborative team care. (C) 2018 American Society for Blood and Marrow Transplantation.

引用

页码：E145 / E154

页数：10

共 34 条

[31] Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Battipaglia, Giorgia
Labopin, Myriam
Hamladji, Rose-Marie
Blaise, Didier
Chevallier, Patrice
Brissot, Eolia
Gerbitz, Armin
Socie, Gerard
Afanasyev, Boris
Ciceri, Fabio
Meijer, Ellen
Koc, Yener
Cornelissen, Jan J.
Huynh, Anne
Ozdogu, Hakan
Maertens, Johan
Paul, Franciane
Labussiere-Wallet, Helene
Ruggeri, Annalisa
Aljurf, Mahmoud
Bazarbachi, Ali
Savani, Bipin
Nagler, Arnon
Mohty, Mohamad
[J]. CANCER, 2021, 127 (02) : 209 - 218
[32] Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence for at least 2 years after autologous stem cell transplantation: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Czerw, Tomasz
Labopin, Myriam
Gorin, Norbert-Claude
Giebel, Sebastian
Blaise, Didier
Meloni, Giovanna
Pigneux, Arnaud
Bosi, Alberto
Veelken, Joan
Ferrara, Felicetto
Schaap, Nicolaas
Lemoli, Roberto M.
Cornelissen, Jan J.
Beohou, Eric
Nagler, Arnon
Mohty, Mohamad
[J]. CANCER, 2016, 122 (12) : 1880 - 1887
[33] Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation
Ofran, Yishai
Beohou, Eric
Labopin, Myriam
Blaise, Didier
Cornelissen, Jan J.
de Groot, Marco R.
Socie, Gerard
Huynh, Anne
Maertens, Johan
Baron, Frederic
Mohty, Mohamad
Nagler, Arnon
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 643 - 646
[34] Allogeneic Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia in Remission: Comparison of Intravenous Busulfan Plus Cyclophosphamide (Cy) Versus Total-Body Irradiation Plus Cy As Conditioning Regimen-A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Nagler, Arnon
Rocha, Vanderson
Labopin, Myriam
Unal, Ali
Ben Othman, Tarek
Campos, Antonio
Volin, Liisa
Poire, Xavier
Aljurf, Mahmoud
Masszi, Tamas
Socie, Gerard
Sengelov, Henrik
Michallet, Mauricette
Passweg, Jakob
Veelken, Hendrik
Yakoub-Agha, Ibrahim
Shimoni, Avichai
Mohty, Mohamad
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (28) : 3549 - +

← 1 2 3 4 →